-
AstraZeneca’s earnings surprise investors as cancer drugs fuel growth
25 Apr 2024 19:24 GMT
… sales and higher costs meant AstraZeneca missed profit estimates.
However, executives … respectively.
AstraZeneca’s London-traded shares rose 6% following the earnings announcement … , the early-stage pipeline suggests AstraZeneca is exploring some higher-risk …
-
AstraZeneca on emerging markets, GLP-1 plans and why it’s selective about vaccines
25 Apr 2024 18:45 GMT
AstraZeneca put the spotlight on its … revenue growth during first-quarter earnings, driven in part by its …
-
AstraZeneca CEO says platform deals largely done after M&As in vaccines, radioligand, cell therapy
25 Apr 2024 17:59 GMT
After AstraZeneca’s recent acquisitions of various … the company’s first-quarter earnings call.
In oncology, AZ last … .”
Soriot’s comment comes as AstraZeneca delivered a strong start to …
-
AstraZeneca Plc (AZN) Q1 2024 Earnings Call Transcript
25 Apr 2024 17:47 GMT
… Fool.
AstraZeneca Plc (AZN 5.82%)
Q1 2024 Earnings Call
… and financial performance of AstraZeneca. Although we believe our … the continuing strength of AstraZeneca's investment proposition … actually, across all geographic AstraZeneca emerging market has been …
-
European Stocks Close Lower As Investors React To Earnings, Economic Data
25 Apr 2024 17:46 GMT
… digesting a slew of earnings updates and economic data … companies reported fairly strong quarterly earnings, weak updates and revenue … year range of 3-5%.
AstraZeneca rallied nearly 6%. Antofagasta, … its outlook for 2024 adjusted earnings per share (EPS) to …
-
Sanofi and AstraZeneca Scrap Several Early-Stage Programs in Q1
25 Apr 2024 17:13 GMT
… , European drugmakers Sanofi and AstraZeneca announced several pipeline cuts in … operations.
Thursday’s Q1 earnings also saw AstraZeneca putting the kibosh on … a “strategic portfolio prioritization.”
Other AstraZeneca assets nixed for portfolio prioritization …
-
FTSE reaches another record level on strong earnings and Anglo American bid
25 Apr 2024 16:55 GMT
The biggest risers on the FTSE 100 were Anglo American, up 355p to 2,560p, Barclays, up 12.86p to 204p, AstraZeneca, up 674p to 12,026p, Unilever, up 219p to 4,082p, and Antofagasta, up 61p to 2,227p.
-
Sanofi Reports Strong Earnings, Joins Kirby, Sonic Automotive, Union Pacific And Other Big Stocks Moving Higher On Thursday
25 Apr 2024 14:55 GMT
… than-expected first-quarter earnings.
Sanofi reported first- … 17.78 following strong earnings.
Deutsche Bank Aktiengesellschaft DB … 54.57 following upbeat earnings.
Carrier Global Corporation … 21 following first-quarter earnings.
AstraZeneca PLC AZN climbed 5 …
-
AstraZeneca reports bumper revenue in Q1 2024 on strong drug demand
25 Apr 2024 14:37 GMT
… AstraZeneca reported its first quarter 2024 earnings on Thursday, seeing extremely robust earnings … executive officer (CEO) of AstraZeneca said in its earnings release. “Our strong …
-
Drugmaker Sanofi's Strong Dupixent And Beyfortus Vaccine Sales Propel Q1 Earnings
25 Apr 2024 14:20 GMT
Thursday, Sanofi SA SNY reported first-quarter operating income of 2.8 billion euros, down 14.7% Y/Y and 4.2% on constant currency.
The French drugmaker reported adjusted EPS of $0.97 (1.78 euros), beating the consensus estimate of $0.94.
Also Read: In …